Ovid Therapeutics
OVID
OVID
62 hedge funds and large institutions have $110M invested in Ovid Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
-5
Holders Change %
-7.46%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
22
Reduced
17
Closed
12
Calls
$231K
Puts
–
Net Calls
+$231K
Net Calls Change
-$966K
Top Buyers
1 |
CA
CHI Advisors
New York
|
+$1.42M |
2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.13M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$770K |
4 |
BI
BVF Inc
San Francisco,
California
|
+$691K |
5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$665K |